BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25871476)

  • 1. Claudin-4 is required for vasculogenic mimicry formation in human breast cancer cells.
    Cui YF; Liu AH; An DZ; Sun RB; Shi Y; Shi YX; Shi M; Zhang Q; Wang LL; Feng Q; Pan GL; Wang Q
    Oncotarget; 2015 May; 6(13):11087-97. PubMed ID: 25871476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.
    Paulis YW; Huijbers EJ; van der Schaft DW; Soetekouw PM; Pauwels P; Tjan-Heijnen VC; Griffioen AW
    Oncotarget; 2015 Aug; 6(23):19634-46. PubMed ID: 26189059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
    Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
    Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
    Shang X; Lin X; Alvarez E; Manorek G; Howell SB
    Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin-4 controls the proliferation, apoptosis, migration and in vivo growth of MCF-7 breast cancer cells.
    Ma X; Miao H; Jing B; Pan Q; Zhang H; Chen Y; Zhang D; Liang Z; Wen Z; Li M
    Oncol Rep; 2015 Aug; 34(2):681-90. PubMed ID: 26058359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.
    Yang Y; Cheon S; Jung MK; Song SB; Kim D; Kim HJ; Park H; Bang SI; Cho D
    Biochem Biophys Res Commun; 2015 Apr; 459(3):379-86. PubMed ID: 25727011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.
    Liu TJ; Sun BC; Zhao XL; Zhao XM; Sun T; Gu Q; Yao Z; Dong XY; Zhao N; Liu N
    Oncogene; 2013 Jan; 32(5):544-53. PubMed ID: 22469978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 34a-AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells.
    Lim D; Cho JG; Yun E; Lee A; Ryu HY; Lee YJ; Yoon S; Chang W; Lee MS; Kwon BS; Kim J
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptotic effect of claudin-1 on TNF-α-induced apoptosis in human breast cancer MCF-7 cells.
    Liu Y; Wang L; Lin XY; Wang J; Yu JH; Miao Y; Wang EH
    Tumour Biol; 2012 Dec; 33(6):2307-15. PubMed ID: 22941467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claudin-4 is required for modulation of paracellular permeability by muscarinic acetylcholine receptor in epithelial cells.
    Cong X; Zhang Y; Li J; Mei M; Ding C; Xiang RL; Zhang LW; Wang Y; Wu LL; Yu GY
    J Cell Sci; 2015 Jun; 128(12):2271-86. PubMed ID: 25948584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of grape seed proanthocyanidins on tumor vasculogenic mimicry in human triple-negative breast cancer cells.
    Luan YY; Liu ZM; Zhong JY; Yao RY; Yu HS
    Asian Pac J Cancer Prev; 2015; 16(2):531-5. PubMed ID: 25684483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line.
    Maroufi NF; Rashidi M; Vahedian V; Jahanbazi R; Mostafaei S; Akbarzadeh M; Kazemzadeh H; Nejabati HR; Isazadeh A; Rashidi MR; Nouri M
    Breast Cancer; 2022 Mar; 29(2):260-273. PubMed ID: 34725795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal caspase-3 activity promotes migration, invasion, and vasculogenic mimicry formation of melanoma cells.
    Liu YR; Sun B; Zhao XL; Gu Q; Liu ZY; Dong XY; Che N; Mo J
    Melanoma Res; 2013 Aug; 23(4):243-53. PubMed ID: 23695439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
    Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
    Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
    Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
    Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
    Ju RJ; Li XT; Shi JF; Li XY; Sun MG; Zeng F; Zhou J; Liu L; Zhang CX; Zhao WY; Lu WL
    Biomaterials; 2014 Aug; 35(26):7610-21. PubMed ID: 24912818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic reticulum stress inhibits 3D Matrigel-induced vasculogenic mimicry of breast cancer cells via TGF-β1/Smad2/3 and β-catenin signaling.
    Liu H; Wang H; Chen D; Gu C; Huang J; Mi K
    FEBS Open Bio; 2021 Sep; 11(9):2607-2618. PubMed ID: 34320274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma.
    Liu T; Sun B; Zhao X; Gu Q; Dong X; Yao Z; Zhao N; Chi J; Liu N; Sun R; Ma Y
    J Cell Mol Med; 2013 Jan; 17(1):116-22. PubMed ID: 23279650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.